USPTO serial 90517791
MEDICATION INTELLIGENCE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- QUEEN, ESTHER FELICIA
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MEDICATION INTELLIGENCE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Alexandria, VA
ALEXANDRIA, VA
Alexandria, VA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gregory B. Phillips
Gregory B. Phillips KNOBBE MARTENS OLSON & BEAR, LLP2040 MAIN STREET, 14TH FLOORIRVINE, CA 92614United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 006 | Metal boxes | ACTIVE | — |
| 009 | RFID scanning readers for tracking and taking inventory of pharmaceuticals and medical supplies | ACTIVE | — |
| 012 | Carts; Mobile storage carts for commercial use; Mobile storage carts for dispensing pharmaceuticals and medical supplies | ACTIVE | — |
| 042 | Providing temporary use of non-downloadable computer software for tracking and taking inventory of pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for auditing medical records and medication dispensing systems; Providing temporary use of non-downloadable computer software for reporting data in medical records and medication dispensing systems; Providing temporary use of non-downloadable computer software for assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution process; Providing temporary use of non-downloadable computer software for tracking pharmaceuticals and medical supplies including collecting, organizing, disseminating, creating analytic and statistic models, and reporting data regarding the manufacture, inspection, regulatory compliance, supply, distribution, attributes, and sale of pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for tracking pharmaceuticals and medical supplies including collecting, organizing, disseminating, creating analytic and statistic models, and reporting data regarding the persons, entities, systems and machines that have participated in the manufacture, inspection, regulatory compliance, supply, distribution, attributes, and sale of pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for dispensing pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for administering pharmaceuticals; Providing temporary use of non-downloadable computer software for supply chain management systems for pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for inventory management systems for pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for collecting, organizing, disseminating, creating analytic and statistic models, and reporting data contained in electronic medical records, pharmaceutical purchasing systems, supply chain management systems, inventory management systems, pharmaceutical manufacturing systems, pharmaceutical regulatory systems, and pharmaceutical compliance and surveillance systems; Providing temporary use of non-downloadable computer software for implementing industry standards in connection with pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Providing temporary use of non-downloadable computer software for implementing industry standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for implementing industry standards in connection with tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for tracking and taking inventory of pharmaceuticals and medical supplies; Software as a service (SAAS) services featuring software for auditing medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for reporting data in medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution process; Software as a service (SAAS) services featuring software for tracking pharmaceuticals and medical supplies including collecting, organizing, disseminating, creating analytic and statistic models, and reporting data regarding the manufacture, inspection, regulatory compliance, supply, distribution, attributes, and sale of pharmaceuticals and medical supplies; Software as a service (SAAS) services featuring software for tracking pharmaceuticals and medical supplies including collecting, organizing, disseminating, creating analytic and statistic models, and reporting data regarding the persons, entities, systems and machines that have participated in the manufacture, inspection, regulatory compliance, supply, distribution, attributes, and sale of pharmaceuticals and medical supplies; Software as a service (SAAS) services featuring software for dispensing pharmaceuticals and medical supplies; Software as a service (SAAS) services featuring software for administering pharmaceuticals; Software as a service (SAAS) services featuring software for supply chain management systems for pharmaceuticals and medical supplies; Software as a service (SAAS) services featuring software for inventory management systems for pharmaceuticals and medical supplies; Software as a service (SAAS) services featuring software for collecting, organizing, disseminating, creating analytic and statistic models, and reporting data contained in electronic medical records, pharmaceutical purchasing systems, supply chain management systems, inventory management systems, pharmaceutical manufacturing systems, pharmaceutical regulatory systems, and pharmaceutical compliance and surveillance systems; Software as a service (SAAS) services featuring software for implementing industry standards in connection with pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Software as a service (SAAS) services featuring software for implementing industry standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals and medical supplies; Software as a service (SAAS) services featuring software for implementing industry standards in connection with tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards in connection with pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Developing quality control, usage, compatibility, and interoperability standards for tracking, dispensing, and taking inventory of pharmaceuticals and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with tracking, auditing, assessing, reviewing, and reporting data found in medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards in connection with tracking and taking inventory of pharmaceuticals and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with auditing medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards in connection with reporting data in medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards in connection with assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution process; Developing quality control, usage, compatibility, and interoperability standards in connection with supply chain management systems for pharmaceuticals and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with inventory management systems for pharmaceuticals and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with implementing industry standards in connection with pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with implementing industry standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with implementing industry standards in connection with tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems; Developing quality control, usage, compatibility, and interoperability standards in connection with implementing industry standards in connection with supply chain management systems for pharmaceuticals and medical supplies; Developing quality control, usage, compatibility, and interoperability standards in connection with implementing industry standards in connection with inventory management systems for pharmaceuticals and medical supplies; Testing, analysis, and evaluation of the goods of others to assure compliance with industry standards; Providing authentication and verification services for others using computer hardware and software for pharmaceuticals, medical dispensing systems, and medical supplies; Developing and maintaining an on-line database for others consisting of a registry of approved identification numbers for use with an authentication and verification service for pharmaceuticals, medication dispensing systems, and medical supplies; Developing and maintaining an on-line database for others consisting of a registry of data regarding the manufacture, inspection, regulatory compliance, supply, distribution, attributes, and sale of pharmaceuticals and medical supplies; Creating and assigning identification numbers and radio frequency identification (RFID) tags for use with an authentication and verification service for pharmaceuticals, medication dispensing systems, and medical supplies; Data warehousing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Kit Check, Inc.
- Other trademarks owned by BLUESIGHT, INC.
- Other trademarks owned by Kit Check, Inc.
- Other trademarks in Class 006
- Other trademarks in Class 009
- Other trademarks in Class 012
- Other trademarks in Class 042
- Similar marks named MEDICATION INTELLIGENCE
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 14, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 14, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 26, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 25, 2025 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Mar 25, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 25, 2024 | EXT5 | SOU EXTENSION 5 FILED | — |
| Nov 25, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 13, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 5, 2024 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jun 5, 2024 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jun 5, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 6, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 4, 2023 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Dec 4, 2023 | EXT3 | SOU EXTENSION 3 FILED | — |
| Dec 4, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 9, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 6, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jun 6, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 6, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 3, 2023 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Apr 19, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 9, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 7, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 7, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 7, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 30, 2022 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Jun 7, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 12, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 12, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 23, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 4, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 28, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 27, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 27, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 27, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 27, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 27, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 20, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 12, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 11, 2021 | NWAP | NEW APPLICATION ENTERED | — |